Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid |
Is a |
Carbinoxamine (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid |
Is a |
Pseudoephedrine-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid |
Is a |
Product containing dextromethorphan (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid |
Is a |
Dextromethorphan hydrobromide (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ethanolamine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Carbinoxamine (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Pseudoephedrine (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dextromethorphan hydrobromide (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid |
Is a |
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Carbinoxamine maleate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Pseudoephedrine hydrochloride |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid |
Has manufactured dose form |
Liquide oral |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent cardiovasculaire |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid |
Is a |
Product manufactured as oral dose form (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|